_id
69131523ccc777a4e85d8042
Ticker
METXF
Name
METXF
Exchange
PINK
Address
177 Robson Street, Vancouver, BC, Canada, V6B 0N3
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.metherapeutics.com
Description
ME Therapeutics Holdings Inc., a preclinical stage biotechnology company, engages in the development of cancer fighting drugs in the field of immuno-oncology. The company's lead candidate, h1B11-12, is a glycoprotein cytokine antibody drug that targets a key protein involved in the generation of suppressive myeloid cells for the treatment of colorectal cancer. It also develops D094 and D099, which are small molecule myeloid targeted prodrug candidates to treat cancer; and myeloid targeting lipid nanoparticles (LNPS) formulations. ME Therapeutics Holdings Inc. was founded in 2014 and is headquartered in Vancouver, Canada.
Last Close
2.95
Volume
-
Current Price
2.95
Change
0
Last Updated
2026-01-05T10:22:29.011Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
88646008
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-08-31
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
343929
Operating Income
-343929
Interest Expense
2822
Pretax Income
-338413
Net Income
-338413
Eps
-0.011436930959346584
Dividends Per Share
-
Shares Outstanding
30049494
Income Tax Expense
-
EBITDA
-
Operating Margin
-
Total Other Income Expense Net
-
Cash
1345377
Short Term Investments
57500
Receivables
-
Inventories
-
Total Current Assets
1502086
Property Plant Equipment
257282
Total Assets
1759369
Payables
155208
Short Term Debt
-
Long Term Debt
-
Total Liabilities
256268
Equity
1503101
Bs_currency_symbol
CAD
Depreciation
26561
Change In Working Capital
63781
Cash From Operations
-245249
Capital Expenditures
44580
Cash From Investing
-
Cash From Financing
-16337
Net Change In Cash
-306166
Cf_currency_symbol
CAD
PE
-
PB
58.07261607836067
ROE
-22.514322058198353
ROA
-19.23490751513753
FCF
-289829
Fcf Percent
-
Piotroski FScore
1
Health Score
35
Deep Value Investing Score
3
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
2
Net Net Investing Score
2.5
Quality Investing Score
2.5
Value Investing Score
4.5
Quarters > 0 > quarter
2025-08-31
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
343929
Quarters > 0 > income Statement > operating Income
-343929
Quarters > 0 > income Statement > interest Expense
2822
Quarters > 0 > income Statement > pretax Income
-338413
Quarters > 0 > income Statement > net Income
-338413
Quarters > 0 > income Statement > eps
-0.011436930959346584
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
29589494
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > income Statement > currency_symbol
CAD
Quarters > 0 > balance Sheet > cash
1345377
Quarters > 0 > balance Sheet > short Term Investments
57500
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
1502086
Quarters > 0 > balance Sheet > property Plant Equipment
257282
Quarters > 0 > balance Sheet > total Assets
1759369
Quarters > 0 > balance Sheet > payables
155208
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
256268
Quarters > 0 > balance Sheet > equity
1503101
Quarters > 0 > balance Sheet > currency_symbol
CAD
Quarters > 0 > cash Flow > net Income
-338413
Quarters > 0 > cash Flow > depreciation
26561
Quarters > 0 > cash Flow > change In Working Capital
63781
Quarters > 0 > cash Flow > cash From Operations
-245249
Quarters > 0 > cash Flow > capital Expenditures
44580
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-16337
Quarters > 0 > cash Flow > net Change In Cash
-306166
Quarters > 0 > cash Flow > currency_symbol
CAD
Quarters > 0 > ratios > PE
-0.011436930959346584
Quarters > 0 > ratios > PB
58.07261607836067
Quarters > 0 > ratios > ROE
-22.514322058198353
Quarters > 0 > ratios > ROA
-19.23490751513753
Quarters > 0 > ratios > FCF
-289829
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
35
Quarters > 1 > quarter
2025-05-31
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
360631
Quarters > 1 > income Statement > operating Income
-360631
Quarters > 1 > income Statement > interest Expense
3317
Quarters > 1 > income Statement > pretax Income
-353447
Quarters > 1 > income Statement > net Income
-353447
Quarters > 1 > income Statement > eps
-0.011945016700860109
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
29589494
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-
Quarters > 1 > income Statement > currency_symbol
CAD
Quarters > 1 > balance Sheet > cash
1651543
Quarters > 1 > balance Sheet > short Term Investments
57500
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
1774318
Quarters > 1 > balance Sheet > property Plant Equipment
239263
Quarters > 1 > balance Sheet > total Assets
2013582
Quarters > 1 > balance Sheet > payables
45752
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
172068
Quarters > 1 > balance Sheet > equity
1841514
Quarters > 1 > balance Sheet > currency_symbol
CAD
Quarters > 1 > cash Flow > net Income
-353447
Quarters > 1 > cash Flow > depreciation
25757
Quarters > 1 > cash Flow > change In Working Capital
59884
Quarters > 1 > cash Flow > cash From Operations
-264489
Quarters > 1 > cash Flow > capital Expenditures
8695
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-16337
Quarters > 1 > cash Flow > net Change In Cash
-347021
Quarters > 1 > cash Flow > currency_symbol
CAD
Quarters > 1 > ratios > PE
-0.011945016700860109
Quarters > 1 > ratios > PB
47.40067536820247
Quarters > 1 > ratios > ROE
-19.193283352719558
Quarters > 1 > ratios > ROA
-17.553146581564594
Quarters > 1 > ratios > FCF
-273184
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
35
Quarters > 2 > quarter
2025-02-28
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
204808
Quarters > 2 > income Statement > operating Income
-204808
Quarters > 2 > income Statement > interest Expense
3793
Quarters > 2 > income Statement > pretax Income
-199979
Quarters > 2 > income Statement > net Income
-199979
Quarters > 2 > income Statement > eps
-0.006758446089007132
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
29589494
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-
Quarters > 2 > income Statement > currency_symbol
CAD
Quarters > 2 > balance Sheet > cash
1998564
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
2083928
Quarters > 2 > balance Sheet > property Plant Equipment
256325
Quarters > 2 > balance Sheet > total Assets
2340254
Quarters > 2 > balance Sheet > payables
8219
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
145293
Quarters > 2 > balance Sheet > equity
2194961
Quarters > 2 > balance Sheet > currency_symbol
CAD
Quarters > 2 > cash Flow > net Income
-199979
Quarters > 2 > cash Flow > depreciation
20478
Quarters > 2 > cash Flow > change In Working Capital
-49528
Quarters > 2 > cash Flow > cash From Operations
-207265
Quarters > 2 > cash Flow > capital Expenditures
154044
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
1033663
Quarters > 2 > cash Flow > net Change In Cash
672354
Quarters > 2 > cash Flow > currency_symbol
CAD
Quarters > 2 > ratios > PE
-0.006758446089007132
Quarters > 2 > ratios > PB
39.76790808583843
Quarters > 2 > ratios > ROE
-9.11082247019423
Quarters > 2 > ratios > ROA
-8.545183556998513
Quarters > 2 > ratios > FCF
-361309
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
34
Quarters > 3 > quarter
2024-11-30
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
308917
Quarters > 3 > income Statement > operating Income
-308917
Quarters > 3 > income Statement > interest Expense
2785
Quarters > 3 > income Statement > pretax Income
-301361
Quarters > 3 > income Statement > net Income
-301361
Quarters > 3 > income Statement > eps
-0.011963757588778877
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
25189494
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-
Quarters > 3 > income Statement > currency_symbol
CAD
Quarters > 3 > balance Sheet > cash
1326210
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
1437280
Quarters > 3 > balance Sheet > property Plant Equipment
122759
Quarters > 3 > balance Sheet > total Assets
1560040
Quarters > 3 > balance Sheet > payables
90272
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
233071
Quarters > 3 > balance Sheet > equity
1326969
Quarters > 3 > balance Sheet > currency_symbol
CAD
Quarters > 3 > cash Flow > net Income
-301361
Quarters > 3 > cash Flow > depreciation
10523
Quarters > 3 > cash Flow > change In Working Capital
-9894
Quarters > 3 > cash Flow > cash From Operations
-145344
Quarters > 3 > cash Flow > capital Expenditures
8834
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-5446
Quarters > 3 > cash Flow > net Change In Cash
-170515
Quarters > 3 > cash Flow > currency_symbol
CAD
Quarters > 3 > ratios > PE
-0.011963757588778877
Quarters > 3 > ratios > PB
55.99905295451514
Quarters > 3 > ratios > ROE
-22.710477788102057
Quarters > 3 > ratios > ROA
-19.317517499551293
Quarters > 3 > ratios > FCF
-154178
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
35
Annuals > 0 > quarter
2025-08-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
1218285
Annuals > 0 > income Statement > operating Income
-1218285
Annuals > 0 > income Statement > interest Expense
12717
Annuals > 0 > income Statement > pretax Income
-1193200
Annuals > 0 > income Statement > net Income
-1193200
Annuals > 0 > income Statement > eps
-0.04032512350498457
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
29589494
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-
Annuals > 0 > income Statement > currency_symbol
CAD
Annuals > 0 > balance Sheet > cash
1345377
Annuals > 0 > balance Sheet > short Term Investments
57500
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
1502086
Annuals > 0 > balance Sheet > property Plant Equipment
257282
Annuals > 0 > balance Sheet > total Assets
1759369
Annuals > 0 > balance Sheet > payables
155208
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
256268
Annuals > 0 > balance Sheet > equity
1503101
Annuals > 0 > balance Sheet > currency_symbol
CAD
Annuals > 0 > cash Flow > net Income
-1193200
Annuals > 0 > cash Flow > depreciation
83319
Annuals > 0 > cash Flow > change In Working Capital
64243
Annuals > 0 > cash Flow > cash From Operations
-862347
Annuals > 0 > cash Flow > capital Expenditures
216153
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
995543
Annuals > 0 > cash Flow > net Change In Cash
-151348
Annuals > 0 > cash Flow > currency_symbol
CAD
Annuals > 0 > ratios > PE
-0.04032512350498457
Annuals > 0 > ratios > PB
58.07261607836067
Annuals > 0 > ratios > ROE
-79.38255646160837
Annuals > 0 > ratios > ROA
-67.81976947416943
Annuals > 0 > ratios > FCF
-1078500
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
27
Annuals > 1 > quarter
2024-08-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
-
Annuals > 1 > income Statement > operating Expenses
1326452
Annuals > 1 > income Statement > operating Income
-1326452
Annuals > 1 > income Statement > interest Expense
0
Annuals > 1 > income Statement > pretax Income
-1294635
Annuals > 1 > income Statement > net Income
-1294635
Annuals > 1 > income Statement > eps
-0.05139583192897801
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
25189494
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-
Annuals > 1 > income Statement > currency_symbol
CAD
Annuals > 1 > balance Sheet > cash
1496725
Annuals > 1 > balance Sheet > short Term Investments
0
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
1538487
Annuals > 1 > balance Sheet > property Plant Equipment
157
Annuals > 1 > balance Sheet > total Assets
1538645
Annuals > 1 > balance Sheet > payables
46138
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
62918
Annuals > 1 > balance Sheet > equity
1475727
Annuals > 1 > balance Sheet > currency_symbol
CAD
Annuals > 1 > cash Flow > net Income
-1294635
Annuals > 1 > cash Flow > depreciation
39
Annuals > 1 > cash Flow > change In Working Capital
-62798
Annuals > 1 > cash Flow > cash From Operations
-657920
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
1507500
Annuals > 1 > cash Flow > net Change In Cash
849580
Annuals > 1 > cash Flow > currency_symbol
CAD
Annuals > 1 > ratios > PE
-0.05139583192897801
Annuals > 1 > ratios > PB
50.354169368724705
Annuals > 1 > ratios > ROE
-87.72862460333111
Annuals > 1 > ratios > ROA
-84.14124115699202
Annuals > 1 > ratios > FCF
-657920
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
27
Annuals > 2 > quarter
2023-08-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
-
Annuals > 2 > income Statement > operating Expenses
977371
Annuals > 2 > income Statement > operating Income
-977371
Annuals > 2 > income Statement > interest Expense
7462
Annuals > 2 > income Statement > pretax Income
-6520390
Annuals > 2 > income Statement > net Income
-6520390
Annuals > 2 > income Statement > eps
-0.27674381146385113
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
23561105
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-5546968
Annuals > 2 > income Statement > currency_symbol
CAD
Annuals > 2 > balance Sheet > cash
647145
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
671664
Annuals > 2 > balance Sheet > property Plant Equipment
196
Annuals > 2 > balance Sheet > total Assets
671861
Annuals > 2 > balance Sheet > payables
106716
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
148473
Annuals > 2 > balance Sheet > equity
523388
Annuals > 2 > balance Sheet > currency_symbol
CAD
Annuals > 2 > cash Flow > net Income
-6520390
Annuals > 2 > cash Flow > depreciation
49
Annuals > 2 > cash Flow > change In Working Capital
42580
Annuals > 2 > cash Flow > cash From Operations
-303195
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
115525
Annuals > 2 > cash Flow > net Change In Cash
569768
Annuals > 2 > cash Flow > currency_symbol
CAD
Annuals > 2 > ratios > PE
-0.27674381146385113
Annuals > 2 > ratios > PB
132.79872627954788
Annuals > 2 > ratios > ROE
-1245.8042599371786
Annuals > 2 > ratios > ROA
-970.4968736092733
Annuals > 2 > ratios > FCF
-303195
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
26
Annuals > 3 > quarter
2022-08-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
295267
Annuals > 3 > income Statement > operating Income
-295267
Annuals > 3 > income Statement > interest Expense
10800
Annuals > 3 > income Statement > pretax Income
-3304769
Annuals > 3 > income Statement > net Income
-3304769
Annuals > 3 > income Statement > eps
-0.14026375248529302
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
23561105
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-3001526
Annuals > 3 > income Statement > currency_symbol
CAD
Annuals > 3 > balance Sheet > cash
397912
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
397912
Annuals > 3 > balance Sheet > property Plant Equipment
245
Annuals > 3 > balance Sheet > total Assets
397912
Annuals > 3 > balance Sheet > payables
34175
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
60000
Annuals > 3 > balance Sheet > total Liabilities
35370
Annuals > 3 > balance Sheet > equity
362542
Annuals > 3 > balance Sheet > currency_symbol
CAD
Annuals > 3 > cash Flow > net Income
-3304769
Annuals > 3 > cash Flow > depreciation
61
Annuals > 3 > cash Flow > change In Working Capital
-14445
Annuals > 3 > cash Flow > cash From Operations
-135685
Annuals > 3 > cash Flow > capital Expenditures
0
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
140000
Annuals > 3 > cash Flow > net Change In Cash
4315
Annuals > 3 > cash Flow > currency_symbol
CAD
Annuals > 3 > ratios > PE
-0.14026375248529302
Annuals > 3 > ratios > PB
191.716434923402
Annuals > 3 > ratios > ROE
-911.5547991680965
Annuals > 3 > ratios > ROA
-830.5276040933674
Annuals > 3 > ratios > FCF
-135685
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
26
Valuation > metrics > PE
-0.011436930959346584
Valuation > metrics > PB
58.07261607836067
Valuation > final Score
20
Valuation > verdict
1835.8% Overvalued
Profitability > metrics > ROE
-22.514322058198353
Profitability > metrics > ROA
-22.529535592502693
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.17049286774474903
Risk > metrics > Interest Coverage
-121.87420269312544
Risk > final Score
-427
Risk > verdict
High
Liquidity > metrics > Current Ratio
9.67789031493222
Liquidity > metrics > Quick Ratio
9.67789031493222
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
15
Prev Risks > 0
-375
Prev Risks > 1
-156
Prev Risks > 2
-384
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:11:57.414Z
Earnings History > 0 > period
2025-08-31
Earnings History > 0 > report Date
2025-08-31
Earnings History > 0 > date
2025-08-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.0083
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-05-31
Earnings History > 1 > report Date
2025-05-31
Earnings History > 1 > date
2025-05-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.0085
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-02-28
Earnings History > 2 > report Date
2025-02-28
Earnings History > 2 > date
2025-02-28
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.0052
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-11-30
Earnings History > 3 > report Date
2024-11-30
Earnings History > 3 > date
2024-11-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.0087
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-08-31
Earnings History > 4 > report Date
2024-08-31
Earnings History > 4 > date
2024-08-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
CAD
Earnings History > 4 > eps Actual
-0.009
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
ME Therapeutics Holdings Inc., a preclinical stage biotechnology company, engages in the development of cancer fighting drugs in the field of immuno-oncology. The company's lead candidate, h1B11-12, is a glycoprotein cytokine antibody drug that targets a key protein involved in the generation of suppressive myeloid cells for the treatment of colorectal cancer. It also develops D094 and D099, which are small molecule myeloid targeted prodrug candidates to treat cancer; and myeloid targeting lipid nanoparticles (LNPS) formulations. ME Therapeutics Holdings Inc. was founded in 2014 and is headquartered in Vancouver, Canada.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-08-31)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of METXF
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-08-31
EPS Actual
-0.0083
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-08-31)
(Last Updated 2025-08-31)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-08-31)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-08-31)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.